CN1895403A - Compound Chinese medicine for treating bone stitch and its preparation - Google Patents
Compound Chinese medicine for treating bone stitch and its preparation Download PDFInfo
- Publication number
- CN1895403A CN1895403A CN 200610085406 CN200610085406A CN1895403A CN 1895403 A CN1895403 A CN 1895403A CN 200610085406 CN200610085406 CN 200610085406 CN 200610085406 A CN200610085406 A CN 200610085406A CN 1895403 A CN1895403 A CN 1895403A
- Authority
- CN
- China
- Prior art keywords
- fructus
- herba
- medicine
- kidney
- bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 89
- 210000000988 bone and bone Anatomy 0.000 title claims description 45
- 150000001875 compounds Chemical class 0.000 title claims description 17
- 238000002360 preparation method Methods 0.000 title claims description 12
- 239000002775 capsule Substances 0.000 claims abstract description 14
- 239000003826 tablet Substances 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 29
- 210000000582 semen Anatomy 0.000 claims description 21
- 241000005787 Cistanche Species 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 9
- 238000012856 packing Methods 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 229960004793 sucrose Drugs 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 229940057948 magnesium stearate Drugs 0.000 claims description 2
- 229940032147 starch Drugs 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 27
- 230000036407 pain Effects 0.000 abstract description 25
- 238000000034 method Methods 0.000 abstract description 11
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 241000893536 Epimedium Species 0.000 abstract description 3
- 240000006079 Schisandra chinensis Species 0.000 abstract description 3
- 235000018905 epimedium Nutrition 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 235000008599 Poria cocos Nutrition 0.000 abstract description 2
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract description 2
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 51
- 230000000694 effects Effects 0.000 description 22
- 206010005963 Bone formation increased Diseases 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 210000003205 muscle Anatomy 0.000 description 18
- 230000007812 deficiency Effects 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 15
- 230000006870 function Effects 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 238000005728 strengthening Methods 0.000 description 12
- 230000027939 micturition Effects 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 201000001881 impotence Diseases 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 244000052769 pathogen Species 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000000629 knee joint Anatomy 0.000 description 8
- 238000004064 recycling Methods 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 210000002435 tendon Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 206010059013 Nocturnal emission Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 208000008035 Back Pain Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 208000008967 Enuresis Diseases 0.000 description 5
- 208000010228 Erectile Dysfunction Diseases 0.000 description 5
- 208000008930 Low Back Pain Diseases 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 230000008093 supporting effect Effects 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010010144 Completed suicide Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010021118 Hypotonia Diseases 0.000 description 4
- 206010041497 Spermatorrhoea Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 208000017561 flaccidity Diseases 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 108010048734 sclerotin Proteins 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000031975 Yang Deficiency Diseases 0.000 description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 229940067131 aspirin 100 mg Drugs 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 208000019902 chronic diarrheal disease Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229960005181 morphine Drugs 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- WGJXEOWVZFMOMC-UHFFFAOYSA-N Agrimonic acid A Natural products OC(=O)c1cc(O)c(O)c(Oc2c(O)c(O)c(O)cc2C(=O)OC3OC4COC(=O)c5cc(O)c(O)c(O)c5c6c(O)c(O)c(O)cc6C(=O)OC4C7OC(=O)c8cc(O)c(O)c(O)c8c9c(O)c(O)c(O)cc9C(=O)OC37)c1 WGJXEOWVZFMOMC-UHFFFAOYSA-N 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 241000903946 Clematidis Species 0.000 description 2
- 241001362421 Epimedium brevicornu Species 0.000 description 2
- 208000036119 Frailty Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 244000296102 Selinum monnieri Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241000053227 Themus Species 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- MUAWJMQXPARDMP-UHFFFAOYSA-N agrimonic acids A Natural products OC(=O)c1cc(O)c(O)c(O)c1Oc2cc(cc(O)c2O)C(=O)OC3OC4COC(=O)c5cc(O)c(O)c(O)c5c6c(O)c(O)c(O)cc6C(=O)OC4C7OC(=O)c8cc(O)c(O)c(O)c8c9c(O)c(O)c(O)cc9C(=O)OC37 MUAWJMQXPARDMP-UHFFFAOYSA-N 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- -1 flavone glucoside Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 2
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000004994 reproductive system Anatomy 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- IRZTUXPRIUZXMP-UHFFFAOYSA-N rubiadin Chemical compound C1=CC=C2C(=O)C3=C(O)C(C)=C(O)C=C3C(=O)C2=C1 IRZTUXPRIUZXMP-UHFFFAOYSA-N 0.000 description 2
- 210000001625 seminal vesicle Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 230000003393 splenic effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 201000010653 vesiculitis Diseases 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 244000139693 Arctostaphylos uva ursi Species 0.000 description 1
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241000499399 Cynomoriaceae Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- RTZKSTLPRTWFEV-OLZOCXBDSA-N Deoxygomisin A Chemical compound COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3C[C@@H](C)[C@@H](C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-OLZOCXBDSA-N 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010060766 Heteroplasia Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- RTZKSTLPRTWFEV-UHFFFAOYSA-N Isokadsuranin Natural products COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3CC(C)C(C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-UHFFFAOYSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000308150 Orobanchaceae Species 0.000 description 1
- 206010057178 Osteoarthropathies Diseases 0.000 description 1
- 208000008558 Osteophyte Diseases 0.000 description 1
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000123889 Rubus chingii Species 0.000 description 1
- 241000736078 Schisandra sphenanthera Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 235000019084 Selinum monnieri Nutrition 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000021945 Tendon injury Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002223 anti-pathogen Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000459 calcaneus Anatomy 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- JEJFTTRHGBKKEI-OKILXGFUSA-N deoxyschizandrin Chemical compound C1[C@H](C)[C@H](C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-OKILXGFUSA-N 0.000 description 1
- JEJFTTRHGBKKEI-UHFFFAOYSA-N deoxyschizandrin Natural products C1C(C)C(C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- MBPYHNAWMKVREM-UHFFFAOYSA-N isostrictinin Natural products C12OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(O)C(CO)OC1OC(=O)C1=CC(O)=C(O)C(O)=C1 MBPYHNAWMKVREM-UHFFFAOYSA-N 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- YLHKRZUROLLGIA-UHFFFAOYSA-N laevigatin A Natural products OCC1CC(OC(=O)c2cc(O)c(O)c(Oc3c(O)c(O)c(O)cc3C(=O)O)c2)C4OC(=O)c5cc(O)c(O)c(O)c5c6c(O)c(O)c(O)cc6C(=O)OC4C1O YLHKRZUROLLGIA-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine in the form of capsule, tablet, or particle for treating spur pain is prepared from 11 Chinese-medicinal materials including dodder seed, schisandra fruit, epimedium, tuckahoe, etc. Its preparing process is also disclosed.
Description
Technical field
What the present invention relates to is a kind of pharmaceutical preparation and preparation method thereof, more particularly, relates to a kind of compound Chinese patent medicine for the treatment of bone stitch and preparation method thereof.A kind of compound Chinese patent medicine for the treatment of bone stitch of the present invention claims " twinge gram " again.
Background technology
Wound, fracture, hyperosteogeny, osteoporosis are the common property of orthopaedics frequently-occurring disease, and its annual morbidity accounts for 10% of population total amount, and promptly annual domestic patient we can say that just up to more than 100,000,000 person-times market is quite big to the demand of this type of medicine.In addition, owing to be subjected to the influence of factors such as vehicle accident, population growth, life stress, the market demand is the impetus that increases year by year.
The clinical of hyperosteogeny is divided into: hyperosteogeny of cervical vertebra, lumbar vertebra hyperosteogeny, knee joint hyperosteogeny.Aspect doctor trained in Western medicine, major part all is to treat with analgesic and hormone at present, to alleviate the sick body symptom.In recent years, orthopaedics Chinese medicine has also won certain market in the world, is accompanied by abroad the understanding to the Western medicine toxic and side effects, and the demand of natural medicine is also being increased year by year.The medicine of treatment hyperosteogeny has JINGFUKANG, GUXIAN PIAN, bony spur spirit, bone spur pain-eliminating liniment or the like both at home and abroad at present, and the said goods because of the limitation of its prescription theory, we can say that curative effect is average, the price height.Aspect the traditional Chinese medical science, all be to remove some slight illness with relaxing muscles and tendons to promote blood circulation, expelling wind and removing dampness.The prescription that most of traditional Chinese medical science are left all is to use some following traditional Chinese medicines, and as the Radix Paeoniae Alba, Fructus Chaenomelis, Radix Glycyrrhizae, Sanguis Gallus domesticus knee joint, Radix Clematidis, Radix Puerariae, Fructus Lycii, the Cortex Eucommiae, Niu Xi, Radix Angelicae Sinensis, Retinervus Luffae Fructus, Ramulus Uncariae Cum Uncis or the like, and effect can only solve patient surface pain problem.
Summary of the invention
The objective of the invention is provides a kind of compound Chinese patent medicine for the treatment of bone stitch and preparation method thereof at above-mentioned weak point, we draft under the theoretical direction of Chinese medicine " kidney governing bones ", make sclerotin obtain the filling of material and repair, fundamentally solve the pain of bony spur.
The present invention is prescription under the theory of Chinese medicine " kidney governing bones ", thinks that bony spur is owing to suffer from a deficiency of the kidney, and can not give birth to that marrow fills bone and the regression that causes bone so the present invention solves patient's the body constitution of suffering from a deficiency of the kidney earlier, is effected a radical cure the pain that bony spur causes from the source.The present invention can greatly improve patient's quality of life, satisfies patient's urgent needs.
Hyperosteogeny belongs to the traditional Chinese medical science " arthromyodynia " category, and good sending out in 35～70 years old age bracket can be described as a kind of normal physiological phenomena.Because motion and work are many, wearing and tearing impelling joint, joint produces the degeneration bone and becomes, about 80% people more or less hyperosteogeny can occur more than 60 years old.Because China just progressively enters the society of aging, so treatment hyperosteogeny, the medicine that alleviates affected part pain are had great demand.
Hyperosteogeny also makes bone perverse, or title hyperosteogeny, motherland's medical science is referred to as " rheumatism involving the bone ", it is at the vertebra edge or the edge, joint, the outgrowth sclerotin of articular surface and apophysis place is a kind of performance of osteoarthritis, if tissue such as the nerve around the outgrowth sclerotin compressing, blood vessel or when influencing joint motion, corresponding symptoms can appear, i.e. hyperosteogeny or title hypertrophy osteoarthropathy.Hyperosteogeny is found in the heavy burden joint at any position of human body, and is the most common with cervical vertebra, calcaneus, lumbar vertebra, kneecap joint, is one of common ailment of middle-aged and old.Its main clinical manifestation is an affected part pain, and companion acid is expanded numb, and the patient quite thinks hardship, as calcanean spur whenever just upright, severe pain is unbearably when just walking; Cervical vertebra bony spur can cause neck, shoulder, arm, back radiated pain, and headache is felt sick, and is dizzy, dampings off.
The traditional Chinese medical science is thought " kidney governing bones, liver governing tendons, muscle invest bone ", and cervical spondylosis, prolapse of lumbar intervertebral disc, hyperosteogeny and osteoporosis diseases all are the pathological changes of muscles and bones.Middle-aged and elderly people is because hepatic and renal function decline, and suffering from a deficiency of the kidney can not nourishing bone, and deficiency of liver-blood is with nourishing muscle and tendon, adds that soaking of wind-cold damp pathogen attack, or the wound strain, causes qi-blood disharmony, blockage of main and collateral channels, and various symptoms such as pain discomfort, the numb and movable obstruction of body appear in stagnation of QI and blood may bring about pain.
The clinical of hyperosteogeny is divided into: hyperosteogeny of cervical vertebra, lumbar vertebra hyperosteogeny, knee joint hyperosteogeny.Aspect doctor trained in Western medicine, major part all is to treat with analgesic and hormone at present, to alleviate the sick body symptom.Aspect the traditional Chinese medical science, all be to remove some slight illness with relaxing muscles and tendons to promote blood circulation, expelling wind and removing dampness.The prescription that most of traditional Chinese medical science are left all is to use some following traditional Chinese medicines, and as the Radix Paeoniae Alba, Fructus Chaenomelis, Radix Glycyrrhizae, Sanguis Gallus domesticus knee joint, Radix Clematidis, Radix Puerariae, Fructus Lycii, the Cortex Eucommiae, Niu Xi, Radix Angelicae Sinensis, Retinervus Luffae Fructus, Ramulus Uncariae Cum Uncis or the like, and effect can only solve patient surface pain problem.We draft under the theoretical direction of Chinese medicine " kidney governing bones ", make sclerotin obtain the filling of material and repair, and fundamentally solve the pain of bony spur.
A kind of compound Chinese patent medicine for the treatment of bone stitch and preparation method thereof is to take following scheme to realize:
A kind of compound Chinese patent medicine that is used for the treatment of bone stitch is characterized in that the compound Chinese patent medicine agent that it is made by following Chinese crude drug raw material by weight ratio:
Fructus Rubi 200～220, Rhizoma Drynariae 88～94, Semen Cuscutae 57～63, Fructus Schisandrae Chinensis 47～52, Fructus Rosae Laevigatae 38～43, Herba Epimedii 28～32, Poria 29～33, Radix Morindae Officinalis 27～31, Herba Cynomorii 18～22, Fructus Cnidii 28～33, Herba Cistanches 27～33.
A kind of compound Chinese patent medicine that is used for the treatment of bone stitch, its pharmaceutical preparation are capsule
A kind of preparation method that is used for the treatment of the compound Chinese patent medicine of bone stitch: press following weight proportion weighing Chinese crude drug raw material:
Fructus Rubi 200～220, Rhizoma Drynariae 88～94, Semen Cuscutae 57～63, Fructus Schisandrae Chinensis 47～52, Fructus Rosae Laevigatae 38～43, Herba Epimedii 28～32, Poria 29～33, Radix Morindae Officinalis 27～31, Herba Cynomorii 18～22, Fructus Cnidii 28～33, Herba Cistanches 27～33;
After above-mentioned load weighted Chinese crude drug raw material selected, cleans, twice of 70～90% alcohol heating reflux of 7～12 times of amounts of adding, each 0.5～2.5 hour, filter, the filtrate concentrate drying, pulverize Chinese medicine extract, granulate after crossing 80～120 mesh sieves, divide the capsule of packing into, or the adding pharmaceutic adjuvant is pressed into tablet or is distributed into granule.
Described Chinese medicine extract and pharmaceutic adjuvant weight proportion are 1: 0.5～4.
Described pharmaceutic adjuvant is selected a kind of or mixture in Pulvis Talci, microcrystalline Cellulose, starch, magnesium stearate, cane sugar powder, the dextrin for use.
The theory of Chinese medicine " kidney governing bones " thinks, bony spur is owing to suffer from a deficiency of the kidney, and can not give birth to that marrow fills bone and the regression that causes bone, so under this theory, draft we.But Herba Epimedii, Semen Cuscutae kidney-replenishing, dredging DU Meridian arteries and veins in the side, warming the kidney to invigorate YANG is a monarch drug; Rhizoma Drynariae is got it can invigorating the liver and kidney, again can bone and muscle strengthening, and the kidney invigorating bone strengthening, the continuous wound are controlled pain and are ministerial drug; Herba Cistanches has the function of kidney invigorating and YANG supporting, life essence-filling, marrow-benefitting, benefiting essence-blood, loosening bowel to relieve constipation, slow down aging; Radix Morindae Officinalis, warming the kidney to invigorate YANG is arranged, benefit is smart, bone and muscle strengthening, the effect of wind-damp dispelling; But the Herba Cynomorii benefiting essence-blood, moisturize nourishing muscle and tendon and control a little less than the flaccidity; Fructus Rubi, Fructus Schisandrae Chinensis equal attribute temperature sweet in the mouth and acid, it is smart that Fructus Rubi grows, and the Fructus Schisandrae Chinensis hemopoietic though two medicines temperature is not hot not dry, plays the synergism that gentleness is secreted smart nourishing kidney altogether; The Poria tool relieves inflammation or internal heat, the effect of detoxifcation, diuresis, spleen invigorating.
The present invention is totally ten Herba indigoferae Pseudotinctoriae, and its nature,taste and action division is as follows:
Fructus Rubi: Fructus Rubi has another name called that the bubble that tills the land, father-in-law are turned round, the milk mother, is a kind of Chinese medicine of common flat invigorating the liver and kidney.Beginning is stated from " Mingyi Bielu ", is listed in top grade.TAO Hong-Jing is said: " flat, nontoxic, main QI invigorating is made light of one's life by commiting suicide for Fructus Rubi, sweet in the mouth, and order is sent out not white, adopts reality May." amplification on Canon of Materia Medica cloud again: " and Fructus Rubi, rectangular, May green is ripe, and Qin state is a lot of, and Yongxing Hua Zhou also has, and in time, the people adopts and sells in the mountain, and its sour in the mouth is sweet, and outer as Fructus Litchi, Fructus Pruni pseudocerasi is permitted big, and is soft red lovely, loses and adopts a then living maggot." Pharmacopoeia of the People's Republic of China version regulation in 2000 certified products is the fruit of Fructus Rubi (rubus chingii Hu).
The sweet sour tepor of Fructus Rubi, the neutralization of property official report is returned liver, kidney channel, the merit of Bearberry Extract hemostasis.The function the liver and the kidney tonifying, supporing yang reducing urination.Be used for enuresis due to deficiency of the kidney, frequent micturition, impotence and premature ejaculation, emission and spermatorrhea, the cloudy insufficiency of essence of woman etc.Tcm clinical practice is helped in the tonification prescription by Fructus Rubi commonly used.Fructus Rubi is applied to the clinical long history that has, and ancient Chinese medicine doctor all has abundant and enriches.Modern pharmacological research such as anti-aging effects, to the regulating action of reproductive system, to immune effect etc., think Fructus Rubi based on invigorating the liver and kidney, also have arresting seminal emission gas, the effect of reducing urination liquid.Though have invigorating the liver and kidney, arresting seminal emission gas, reducing urination liquid three to act on greatly,, be a kind of good tonic actually based on invigorating the liver and kidney.
Rhizoma Drynariae: Rhizoma Drynariae is the grow nonparasitically upon another plant dry rhizome of Jue class Zhi Wu Tong Herba pteridii latiusculi of perennial Os Draconis section, popular name monkey Rhizoma Zingiberis Recens, hair Rhizoma Zingiberis Recens.Rhizoma Drynariae bitter in the mouth, warm in nature, effect are that the kidney invigorating analgesia, blood circulation-invigorating tendon-strengthening, symplectic bone are cured the wound." property of medicine opinion ": " poison in the main bone, wind blood pain, the five kinds of over strain six types of severe debility disease, a mouthful hands is not received upper heat and lower cold." supplement to the Herbal: " master traumatics fracture, and mends osteomiosis "." Bencao Tujing ": " control and dodge folding muscles and bones trauma ", " again with controlling deafness ", " it is medicinal also to go into married woman's vim and vigour ".Modern pharmacology is analyzed: Rhizoma Drynariae contains liposoluble constituent, flavonoid becomes to grade with other, and its rhizome is starch-containing, glucose, naringin etc.Effects such as bone strengthening, blood fat reducing, heart tonifying and analgesia are arranged.Rhizoma Drynariae is mainly used in controls lumbago due to renal deficiency, the rheumatic lumbago and skelalgia, and the chronic diarrhea of suffering from a deficiency of the kidney, the enuresis, little infantile malnutrition have blood stasis in the abdomen, muscle and tendon injury knochenbruch, congestive edema, pain, alopecia areata, chronic dermatitis and control streptomycin toxicity.
Semen Cuscutae: Semen Cuscutae is a conventional Chinese medicine, is a kind of parasitics plant, be used as medicine with seed, and acrid in the mouth, sweet, property is flat.Return the liver,kidney,spleen warp.The main Liver and kidney, replenishing vital essence to improve eyesight, antidiarrheal of taking a tonic or nourishing food to build up one's health is antiabortive etc.Cure mainly soreness of the waist and knees, sexual impotence, lingering diarrhea, frequent micturition, have a dizzy spell, effect such as visual deterioration, frequent fetal movement, threatened abortion and blood pressure lowering.The Semen Cuscutae beginning is stated from Shennong's Herbal and classifies as top grade." Zhenglei Bencao " draws the speech of Su Song: " Xia Shengmiao such as silk are combined and to be spread on the vegetation, or the false gas of cloud unrooted and giving birth to, six, July is solid, superfine as silkworm egg, khaki, JIUYUE receive adopt dried cruelly ".Li Shizhen (1518-1593 A.D.) is said: " many virgin soils garden old road, its son is gone into ground, and nascent have root, and long its root is autotomyed along careless thing, no Ye Youhua, white is little red, and perfume (or spice) is also attacked the people, solid as not plump bean and carefully, yellow skin.Modern study shows that the Semen Cuscutae seed contains Quercetin, astragalin, hyperin.Herb contains the Semen Cuscutae polysaccharide to lymphocyte tool mitogenesis, also contains lecithin and cephalin.Its pharmacological action has effects such as the gonad function of enhancing, raise immunity.
Fructus Schisandrae Chinensis: Fructus Schisandrae Chinensis is the dry mature fruit of magnoliaceae schisandra Schisandra chinensis (TrucZ.) Baill. or schisandra chinensis Schisandra sphenanthera Rehd.et wils..Sour in the mouth, warm in nature.Return lung, the heart, kidney channel.The energy convergence is astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, mind tranquilizing and the heart calming.Cure mainly the chronic cough dyspnea due to deficiency, emission, frequent urination and enuresis, incessant chronic diarrhea, spontaneous sweating, Tianjin wound is thirsty, palpitation and insomnia." the medical center bun is wanted ": " allay excitement relieving thirst and restlessness, the dream of emesis peace." " property of medicine bun is wanted ": " treat the nocturnal emission lingering diarrhea." " explaining abstruseness of the canon of materia medica ": " controlling nocturnal emission with astringent drugs, arresting sweating." " solar corona ": " and make eye bright, warming the kidney is controlled wind, and the therapeutic method to keep the adverse QI flowing downwards helps digestion, the cholera rotating disk, and mass beside the umbilicus renal mass cold air, consumer edema, regurgitation, trusted subordinate's flatulence is quenched the thirst, and heat clearing away and restlessness relieving is separated the Kaifeng poison, strengthening bone and muscle." modern study shows that Fructus Schisandrae Chinensis mainly contains volatile ingredient (as australene, benzoic acid etc.), lignanoids (as deoxyschizandrin, schisandrin B etc.), organic acid and glycoside etc.Pharmacological research shows, Fructus Schisandrae Chinensis can obviously prolong pentobarbital sodium length of one's sleep, and anticonvulsant action is arranged; The Fructus Schisandrae Chinensis preparation can promote the hepatic glycogen heteroplasia, can promote hepatic glycogen to decompose, and the phosphorylation process of fructose and glucose is strengthened.And liver injury due to the chemical toxicant had protective effect, aged mouse there is certain function in delaying senility.
Fructus Rosae Laevigatae: Fructus Rosae Laevigatae is the fruit of rosaceous plant Fructus Rosae Laevigatae.Sour in the mouth, puckery, property is flat.Return spleen, kidney, urinary bladder channel.But controlling nocturnal emission with astringent drugs, reducing urination, astringing intestine to stop diarrhea, leukorrhagia stopping.Cure mainly seminal emission, spermatorrhea, the enuresis, frequent micturition, chronic diarrhea, chronic dysentery, nebulousurine, leucorrhea, metrorrhagia, proctoptosis, uterine prolapse." another name for Sichuan Province book on Chinese herbal medicine ": " treat the splenic diarrhea dysentery, end normal urination, arresting seminal emission gas.Clothes make us cold-resistant and make light of one's life by commiting suicide for a long time." " the southern regions of the Yunnan Province book on Chinese herbal medicine ": " control with the passing of time dysentery, metrorrhagia leukorrhagia, arresting seminal emission spermatorrhea." " book on Chinese herbal medicine is just ": " and emesis blood, epistaxis, born fluid are received sweating due to debility, hold back asthenic fire, beneficial marrow, and strengthening bone and muscle is mended five and is hidden, the gas that nourishes blood, flat cough, Dingchuan is anxious, treats the palpitation with a distress feeling palpitation with fear, and only the splenic diarrhea, dysentery and Xiao Shui can't help." " book on Chinese herbal medicine is newly organized ": " arresting seminal emission is sliding, ends nocturnal emission, the enuresis, kills proglottid of tapeworm." " property of medicine is wanted in the medical center bun ": " tonifying the lung unboiled water and spleen eliminating pathogen in the liver, controlling nocturnal emission with astringent drugs, astringing QI ".Modern study shows that the Fructus Rosae Laevigatae fruit contains citric acid, malic acid.The Fructus Rosae Laevigatae peel contains multiple hydrolysis-type tannin: laevigatin A, B, C, D, E, F, G, agrimonine, preceding cyanidin B-3, sanguiin H-4, long stalk aristin, Herba potentillae kleinianae tannin, agrimonic acid A and B etc.Fructus Rosae Laevigatae has antivirus action: the Embryo Gallus domesticus evidence, the Fructus Rosae Laevigatae decoct has inhibitory action to several strains of influenza viruses such as PR8.
Herba Epimedii: Herba Epimedii is the stem and leaf of Berberidaceae plant Herba Epimedii Epimedium brevieornum Maxim.Acrid in the mouth, sweet, temperature.Return liver, kidney channel.Kidney invigorating and YANG supporting, strengthening the tendons and bones, expelling wind and removing dampness.Be used for impotence and seminal emission, cold caused by deficiency is sterile, the frequent micturition incontinence, and dyspnea and cough due to deficiency of the kidney, soreness of the waist and knees, rheumatic arthralgia, hemiplegia, extremity are meciless.Shennong's Herbal: " main impotence is hindered extremely, pains in the penis.Diuresis, physical strength profiting, strong will." " Mingyi Bielu ": " and hard muscles and bones, the scrofula that disappears, red carbuncle, skin ulcer is arranged at the bottom, washes, and goes out worm." " Japan hanako materia medica ": " and control all cold wind consumptive disease, mend the waist knee joint, heart tonifying power, the husband is exhausted, and sun does not rise, the exhausted cloudy loss of fecundity of woman, the muscles and bones contraction is anxious, and extremity are not appointed, old man's dusk octogenarian, the middle age is forgetful." " Elementary Medicine book on Chinese herbal medicine ": " and the kidney invigorating void, supporing yang, control the hemiplegia hands and feet caused by paralysis, the extremity munbness." " property of medicine is wanted in the medical center bun ": " mending gate of vitality's Liver and kidney, energy Yang strengthening and life essence tonifying, also cold removing numbness ".Modern study shows that Herba Epimedii contains Herba Epimedii glycoside, organic acid, sugar and trace element.Herba Epimedii is to endocrine effect: 1) Herba Epimedii can promote sexual function to be because gonepoiesis is hyperfunction, after seminal vesicle is full of, and sensation nerve, indirect excitation libido and causing.2) Herba Epimedii main component icariine can obviously promote mouse epididymis and the growth of seminal vesicle childhood, and icariine has the effect of androgen sample.Herba Epimedii is to the influence of function of immune system: 1) kidney deficiency human T-cell quantity, drench rate of rotation, antibody, antigen and reticuloendothelial system phagocytic hypofunction, and treatment all can improve through kidney-reinforcing drugs such as Herba Epimedii.2) studies show that epimedium brevicornum polysaccharide has the effect of enhancing human body immunity function, epimedium brevicornum polysaccharide had both increased spleen antibody-producting cell number by the influence to the spleen antibody-producting cell, promoted each plasma cell to produce antibody again.3) anti-aging effects: Herba Epimedii can be from the old and feeble mechanism of different aspects influence.As influence passage, and prolong trophophase, regulate immunity and excretory system, improve organism metabolism and each organ dysfunction.Can cause old and feeble theory according to the traditional Chinese medical science " the positive deficiency of vital energy ", adopt the rule of treatment of " strengthening the body resistance ", keep normal adrenal cortex function and immunologic function, can postpone ager process and the generation that prevents senile disease.And total flavone glucoside of epimedium has the T cellular immunization of enhancing and B cellular immunization and adrenocortical function, illustrates that the delaying senility function of Herba Epimedii is relevant with functions of immune system.Studies show that Herba Epimedii has. function of resisting osteoporosis.
Poria: Poria is the dry sclerotia of Polyporaceae fungus Poria Poria cocos (Sohw) Wolf..Sweet in the mouth, light is flat.GUIXIN, lung, spleen, kidney channel.But promoting diuresis to eliminate damp pathogen, the spleen invigorating mind calming.Be used for the edema oliguria, the phlegm retention vertigo and palpitation, insufficiency of the spleen lack of appetite, have loose bowels in the loose stool, irritability, palpitation with fear insomnia." herbal classic ": (Poria) " the contrary gas of the main breast side of body, melancholy is angerd frightened evil, probably throbs with fear, and the heart is the knot pain down, cold and heat stuffy sensation with restlessness, cough with dyspnea, mouthful burnt dry tongue, diuresis.Clothes peace soul is reposed not hungry prolonging life for a long time." " not Lu ": (Poria) " only quench one's thirst, like to sleep, big abdomen drenches drop, the disease due to obstruction of QI of middle-JIAO expectorant water, and edema is drenched knot.Open the breast internal organs, transfer visceral-qi, cut down the kidney heresy, long cloudy, physical strength profiting is during guarantor god keeps." " property of medicine opinion ": (Poria) " appetizing, preventing or arresting vomiting is contrary, kind tranquilizing mind, main consumptive lung disease expectorant is stopped up, and controls pediatric epilepsy scared, treats trusted subordinate's distension, married woman's pyretic stranguria." " solar corona ": (Poria) " mend five kinds of strain and seven kinds of impairment, antiabortive, warm waist knee joint, happy Fructus Alpiniae Oxyphyllae, only forgetful." amplification on Canon of Materia Medica: (Poria) " merit of row water is many, heart-spleen boosting." " concise exposition on febrile disease ": (Poria) " slow spleen of infiltration." " pearl sac ": (Poria) " oozes and lets out, quench the thirst, cut down the kidney heresy.Urine at most can be just it, puckery then can profit." " medicine origin ": (Poria) " only quench one's thirst, diuresis, the dehumidifying benefit is dry, and blood and middle QI invigorating are main between sharp waist umbilicus.Control urinary obstruction, it is yellow or red and unfavorable to drown." curing mainly secret wanting " cloud, it is with having five: antidiarrheal one is also; Diuresis two also; Loosing the interspaces of skin and muscles three also; Remove deficiency-heat four also; Born fluid five also ".Modern study shows that Poria mainly contains compositions such as polysaccharide, triterpenes, fatty acid.Poria has diuresis, antitumor action, sedation, Poria also have protect the liver, antiinflammatory, antipathogen effect, also influential to gastrointestinal function.Poria is to Immune Effects: the effect that pachyman body (pachyman, carboxymethyl pachyman, hydroxyethyl pachyman) has the enhancing human body immunity function.
Radix Morindae Officinalis: Radix Morindae Officinalis is the root of Maguireothamnus speciosus Radix Morindae Officinalis.Acrid in the mouth, sweet, slightly warm in nature.Return liver, kidney channel.But reinforcing the kidney and supporting YANG, bone and muscle strengthening, expelling wind and removing dampness.Cure mainly impotence due to deficiency of the kidney, the seminal emission premature ejaculation, few abdomen cold type of pain, incontinence of urine, cold womb is infertile, anemofrigid-damp arthralgia, soreness of the waist and knees, rheumatism beriberi." herbal classic ": " main strong wind pathogen, sexual impotence does not rise, bone and muscle strengthening, settling five organs, invigorating middle warmer increases the will QI invigorating." " not Lu ": " and treat women's head-ornaments urticaria, phase dragging pain in lower abdomen and the moon, the therapeutic method to keep the adverse QI flowing downwards is mended five kinds of over strain, and benefit is smart, sharp man." " solar corona ": " settling five organs, centering gas removes a wind cutting, controls pathogen, treats edema." " detailed outline ": " control beriberi, go the wind disease, the sea of enriching blood ".Modern study shows that the Radix Morindae Officinalis root contains anthraquinone component: Rubiadin etc., root bark contain 23 kinds of elements such as zinc, manganese, ferrum, chromium.Modern pharmacological research shows, Radix Morindae Officinalis has strong effect, antiinflammatory action, effect in increasing leukocyte, influence to the accessory sex organ: male castration children tooth rat oral gavage gives Radix Morindae Officinalis decoct 30g/kg every day, continuous 15 days, seminal fluid capsule, prostate, preputial glands and levator ani weight all there is not obvious influence.The prompting Radix Morindae Officinalis does not have androgen-like action.
Herba Cynomorii: Herba Cynomorii is the dry meat stem of Cynomoriaceae plant Herba Cynomorii Cynomoriumssongaricum Rupr..Sweet in the mouth, warm in nature.Return spleen, kidney, large intestine channel.But kidney-replenishing, benefiting essence-blood, loosening bowel to relieve constipation.It is soft to be used for waist knee joint flaccidity, sexual impotence spermatorrhea, dryness of the intestine constipation." Amplification on Materia Medica addendum ": (Herba Cynomorii) " nourishing YIN gas is controlled void and constipation due to dry stool usefulness." " detailed outline ": (Herba Cynomorii) " moisturized nourishing muscle and tendon, controlled a little less than the flaccidity." " book on Chinese herbal medicine is original ": (Herba Cynomorii) " nourishing YIN blood deficiency fire, emerging positive controlling nocturnal emission with astringent drugs, reinforcing YIN-essence benefit marrow ".Modern study shows that Herba Cynomorii mainly contains compositions such as volatile oil, aminoacid, triterpenes, also contains steroid class, flavonoid and trace element.Pharmacological research shows that Herba Cynomorii has obvious facilitation, the effect of the free radical of removing is arranged, strengthens resisting oxygen lack humoral immune function, has. antiplatelet aggregative activity.
Fructus Cnidii: Fructus Cnidii is the dry mature fruit of samphire cnidium monnieri Cnidium monnieri (L.) Cass..Acrid in the mouth, hardship, warm in nature.Return spleen, kidney channel.The Fructus Cnidii warming the kidney to invigorate YANG, dampness is dispeled the wind, parasite killing.Be used for sexual impotence, cold womb, cold-damp leukorrhagia, arthralgia chiefly caused by damp pathogen lumbago, external treatment vulval eczema, married woman's pudendal pruritus; Trichomonal vaginitis." detailed outline ": Li Shizhen (1518-1593 A.D.) opinion Fructus Cnidii man woman all suitable " cnidium monnieri is the right kidney gate of vitality, the medicine of few positive three warmers edema caused by disorder of QI, product on legendary god of farming's row are not only assisted the man, and useful married woman." " herbal classic ": (Fructus Cnidii) " swell and ache in housewife people's the moon, the impotence in male pruritus due to damp pathogen removes stagnated QI, sharp joint, epilepsy, malignant boil.Clothes are made light of one's life by commiting suicide for a long time "." not Lu ": (Fructus Cnidii) " warming the middle warmer and descending qi makes the dirty heat of married woman's, and son has been made us in man's postcoital protrusion "." property of medicine opinion ": (Fructus Cnidii) " controls man, woman's void, arthralgia chiefly caused by damp pathogen, malicious wind.Bathe men and women's the moon, go air-cooled, big Yiyang thing "." solar corona ": (Fructus Cnidii) " control cold cruelly, warm husband's yang-energy helps the cloudy gas of woman to pounce on the damage blood stasis, and the waist hip is painful, polyhidrosis around the external genitals exudative dermatitis, extremity insensitive impediment, leucorrhea with red and white discharge, urine reducing "." property of medicine is wanted in the medical center bun ": (Fructus Cnidii) " hard kidney, the profit gate of vitality goes the bottom cold-damp, removes the wind parasite killing ".Modern study shows that the Fructus Cnidii fruit contains volatile oil 1.3%, Coumarins chemical compound (as osthole) and other composition and some trace element.Pharmacological research finds that Fructus Cnidii is influential to reproductive system; To the influence of " yang deficiency " animal, influence the metabolism of cyclic nucleotide and prostaglandin in the body and be one of the mechanism of Fructus Cnidii kidney invigorating and YANG supporting effect or approach, the coumarin composition may be the effective ingredient of Fructus Cnidii kidney invigorating and YANG supporting effect simultaneously; Fructus Cnidii has antiinflammatory and bacteriostatic functions, can suppress pathogenic microorganism and parasite.
Herba Cistanches: Herba Cistanches is the chylocaulous of orobanchaceae plant cistanche.Sweet in the mouth, salty, warm in nature.Return kidney, large intestine channel.The Herba Cistanches kidney-replenishing, benefiting essence-blood, intestine moistening road.Cure mainly the sexual impotence of kidney yang deficiency, asthenia of essence and blood, seminal emission, nebulousurine, the frequent micturition heeltap, the lumbago flaccidity of the lower limbs, tinnitus order flower, menstruation is spread out the phase, infertility, dryness of the intestine constipation." herbal classic ": " main five kinds of strain and seven kinds of impairment, invigorating middle warmer remove stem invasion by pathogenic cold burning pain, support the five internal organs, reinforcing YIN-essence, and beneficial vital essence, how sub, (control) Fu Ren mass in the abdomen.Clothes are made light of one's life by commiting suicide for a long time "." not Lu ": " removing the bladder pathogen, (controlling) lumbago, dysentery relieving "." property of medicine opinion ": " beneficial marrow, improving healthy complexion is prolonged life, and controls woman's metrorrhagia, tonifying YANG, big tonification is led red white following "." solar corona ": " it is out of fashion to control the male-sterilisation sun, and the woman is exhausted, and the moon does not produce.Moistening five ZANG-organs, longue meat, warm waist knee joint, the man lets out essence, hematuria is lost drop, leukorrhagia, pain over the perineum ".Modern study shows that the Herba Cistanches chylocaulous contains boschnialoside A, B, C, H.Pharmacological research shows that Herba Cistanches can strengthen low body fluid and the cellular immune function of yang deficiency mice that prednisolone produces; Strengthen monokaryon-macrophage phagocytic ability; Endocrine be can adjust, metabolism and strong effect promoted; Delaying senility function is arranged.
Raw material of the present invention is formed: Fructus Rubi 200～220g, Rhizoma Drynariae 88～94g, Semen Cuscutae 57～63g, Fructus Schisandrae Chinensis 47～52g, Fructus Rosae Laevigatae 38～43g, Herba Epimedii 28～32g, Poria 29～33g, Radix Morindae Officinalis 27～31g, Herba Cynomorii 18～22g, Fructus Cnidii 28～33g, Herba Cistanches 27～33g.
Go up to making the spice of 400～500 capsules, capsular preparation method: after raw material selected, cleans, twice of 70～90% alcohol heating reflux of 7～12 times of amounts of adding, each 0.5～2.5 hour, filter the filtrate concentrate drying, pulverize, granulate after crossing 100 mesh sieves, divide the capsule of packing into, or the adding pharmaceutic adjuvant is pressed into tablet or is distributed into granule.
Its usage and dosage is: each 2, and every day three times.
Raw material of the present invention is formed and can be amplified according to the production scale equal proportion.
The present invention has compared following characteristics with the medicine of existing treatment bony spur pain:
1, curative effect height, effective percentage 95.7%, cure rate 85.9% has made hundreds of patient's rehabilitations through clinical use.
2, reasonable recipe, according to motherland's theory of Chinese medical science, from the essential problem of root solution bony spur pain, through pharmacodynamics test, medicine of the present invention is obvious to the drug effect of animal model.
3, cheap, taking convenience is easy to carry, and has no side effect.
The specific embodiment
By the following examples, in conjunction with results of pharmacodynamic test, further specify the present invention, following embodiment only is used to the present invention is described and to the present invention without limits.
Embodiment 1
Get Fructus Rubi 200g, Rhizoma Drynariae 88g, Semen Cuscutae 57g, Fructus Schisandrae Chinensis 47g, Fructus Rosae Laevigatae 38g, Herba Epimedii 28g, Poria 29g, Radix Morindae Officinalis 27g, Herba Cynomorii 18g, Fructus Cnidii 28g, Herba Cistanches 27g, after selecting, cleaning, twice of 90% alcohol heating reflux of adding 4L, 2 hours for the first time, 0.5 hour for the second time, filter filtrate recycling ethanol, and the vacuum concentration drying, pulverize the 95g Chinese medicine extract.Chinese medicine extract is granulated after crossing 80 mesh sieves, divides the capsule of packing into, every capsules 0.2g that packs into.
Embodiment 2
Get Fructus Rubi 210g, Rhizoma Drynariae 90g, Semen Cuscutae 60g, Fructus Schisandrae Chinensis 50g, Fructus Rosae Laevigatae 40g, Herba Epimedii 30g, Poria 30g, Radix Morindae Officinalis 30g, Herba Cynomorii 20g, Fructus Cnidii 30g, Herba Cistanches 30g, after selecting, cleaning, twice of 80% alcohol heating reflux of adding 6L, 1.5 hours for the first time, 1.5 hours for the second time, filter filtrate recycling ethanol, and the vacuum concentration drying, pulverize the 90g Chinese medicine extract.Chinese medicine extract is granulated after crossing 100 mesh sieves, divides the capsule of packing into, every capsules 0.2g that packs into.
Embodiment 3
Get Fructus Rubi 220g, Rhizoma Drynariae 94g, Semen Cuscutae 63g, Fructus Schisandrae Chinensis 52g, Fructus Rosae Laevigatae 43g, Herba Epimedii 32g, Poria 33g, Radix Morindae Officinalis 31g, Herba Cynomorii 22g, Fructus Cnidii 33g, Herba Cistanches 33g, after selecting, cleaning, twice of 70% alcohol heating reflux of adding 8L, 2.5 hours for the first time, 0.5 hour for the second time, filter filtrate recycling ethanol, and the vacuum concentration drying, pulverize the 106g Chinese medicine extract.Chinese medicine extract is granulated after crossing 120 mesh sieves, divides the capsule of packing into, every capsules 0.2g that packs into.
Embodiment 4
Get Fructus Rubi 220g, Rhizoma Drynariae 94g, Semen Cuscutae 63g, Fructus Schisandrae Chinensis 52g, Fructus Rosae Laevigatae 43g, Herba Epimedii 32g, Poria 33g, Radix Morindae Officinalis 31g, Herba Cynomorii 22g, Fructus Cnidii 33g, Herba Cistanches 33g, after selecting, cleaning, twice of 80% alcohol heating reflux of adding 7L, 1.5 hours for the first time, 1 hour for the second time, filter filtrate recycling ethanol, and the vacuum concentration drying, pulverize the 108g Chinese medicine extract.Chinese medicine extract is granulated after crossing 80 mesh sieves, adds Pulvis Talci 54g, is pressed into tablet, every heavily about 0.2g.
Embodiment 5
Get Fructus Rubi 210g, Rhizoma Drynariae 90g, Semen Cuscutae 60g, Fructus Schisandrae Chinensis 50g, Fructus Rosae Laevigatae 40g, Herba Epimedii 30g, Poria 30g, Radix Morindae Officinalis 30g, Herba Cynomorii 20g, Fructus Cnidii 30g, Herba Cistanches 30g, after selecting, cleaning, twice of 85% alcohol heating reflux of adding 7L, 2.0 hours for the first time, 2.0 hours for the second time, filter filtrate recycling ethanol, and the vacuum concentration drying, pulverize the 93g Chinese medicine extract.Chinese medicine extract is granulated after crossing 100 mesh sieves, adds the 70g microcrystalline Cellulose, is pressed into tablet, every heavily about 0.3g.
Embodiment 6
Get Fructus Rubi 200g, Rhizoma Drynariae 88g, Semen Cuscutae 57g, Fructus Schisandrae Chinensis 47g, Fructus Rosae Laevigatae 38g, Herba Epimedii 28g, Poria 29g, Radix Morindae Officinalis 27g, Herba Cynomorii 18g, Fructus Cnidii 28g, Herba Cistanches 27g, after selecting, cleaning, twice of 90% alcohol heating reflux of adding 5L, 1 hour for the first time, 1 hour for the second time, filter filtrate recycling ethanol, and the vacuum concentration drying, pulverize the 91g Chinese medicine extract.Chinese medicine extract is granulated after crossing 120 mesh sieves, adds 40g microcrystalline Cellulose, 30g starch, 1g magnesium stearate, is pressed into tablet, every heavily about 0.3g.
Embodiment 7
Get Fructus Rubi 200g, Rhizoma Drynariae 88g, Semen Cuscutae 57g, Fructus Schisandrae Chinensis 47g, Fructus Rosae Laevigatae 38g, Herba Epimedii 28g, Poria 29g, Radix Morindae Officinalis 27g, Herba Cynomorii 18g, Fructus Cnidii 28g, Herba Cistanches 27g, after selecting, cleaning, twice of 75% alcohol heating reflux of adding 4.5L, 1.5 hours for the first time, 1.5 hours for the second time, filter filtrate recycling ethanol, and the vacuum concentration drying, pulverize the 94g Chinese medicine extract.Chinese medicine extract is granulated after crossing 100 mesh sieves, adds the 140g cane sugar powder, divides the bag of packing into, every bag of heavily about 1g.
Embodiment 8
Get Fructus Rubi 210g, Rhizoma Drynariae 90g, Semen Cuscutae 60g, Fructus Schisandrae Chinensis 50g, Fructus Rosae Laevigatae 40g, Herba Epimedii 30g, Poria 30g, Radix Morindae Officinalis 30g, Herba Cynomorii 20g, Fructus Cnidii 30g, Herba Cistanches 30g, after selecting, cleaning, twice of 80% alcohol heating reflux of adding 6.5L, 2 hours for the first time, 2 hours for the second time, filter filtrate recycling ethanol, and the vacuum concentration drying, pulverize the 95g Chinese medicine extract.Chinese medicine extract is granulated after crossing 120 mesh sieves, adds 180g cane sugar powder, dextrin 200g, divides the bag of packing into, every bag of heavily about 2g.
Development purpose of the present invention: under the theoretical direction of Chinese medicine " kidney governing bones ", select the Chinese crude drug of kidney-replenishings such as Herba Epimedii, Semen Cuscutae for use, provide new treatment bony spur medicine for clinical.The test of pesticide effectiveness shows that the present invention has antiinflammatory and analgesic activity, and dosage and time-dependent relation are arranged.A kind of compound Chinese patent medicine for the treatment of bone stitch of the present invention claims " twinge gram " again, hereinafter to be referred as " twinge gram ", tests as follows:
The experimental study of twinge gram anti-inflammatory and antalgic drug effect
One, antiinflammatory action:
(1) the rat paw carrageenin causes swollen method:
1, method: adult healthy SD rat 200～300g, male and female half and half, every group 10, divide dosage group (400mg/kg) in solvent control group (0.1%CMC), aspirin 100mg/kg, twinge gram high dose group (800mg/kg), the twinge gram, twinge gram low dose group 200mg/kg).
2, route of administration: irritate stomach (ig); Administration volume: 4ml/kg.
3, experimental implementation: rat successive administration 5 days, press the sterile working the last time after the administration, injection 1% carrageenin (sterile saline configuration) 0.1ml under the left back sufficient plantar aponeurosis of rat.With the micropipet measurement cause scorching before and cause (per hour once) left and right metapedes volume in scorching back 4 hours, cause with it that value is swelling rate (%) before sufficient volume difference/medicine before and after scorching, relatively be subjected to the significance of reagent group and volume matched group difference.
4, experimental result:
| Group | Dosage mg/kg | Cause scorching back swelling rate (%) | |||
| 1h | 2h | 3h | 4h | ||
| Solvent control | 33.6±5.6 | 44.7±9.2 | 60.1±5.7 | 63.1±8.9 | |
| Aspirin | 100 | 18.3±5.5 ** | 23.9±7.4 ** | 35.7±8.4 ** | 40.1±6.7 ** |
| The twinge gram | 800 | 20.5±7.2 ** | 22.3±4.2 ** | 27.1±6.9 ** | 33.2±5.9 ** |
| 400 | 29.2±5.7 ** | 30.1±6.2 ** | 33.4±7.3 ** | 38.9±5.2 ** | |
| 200 | 31.6±7.1 ** | 35.2±7.8 * | 40.1±6.8 ** | 42.3±8.9 * | |
*P＜0.05,
*Compare with the solvent control group p＜0.01
(2) the scorching method of mouse ear caused by dimethylbenzene xylene
1, method: 26～30g male mouse of kunming is divided into 5 groups, 15 every group at random.Experiment divides dosage group (400mg/kg), twinge gram low dose group (200mg/kg) in solvent control group (0.1%CMC), aspirin 100mg/kg, twinge gram high dose group (800mg/kg), the twinge gram.
2, route of administration: irritate stomach (ig); Administration volume: 20ml/kg.
3, experimental implementation: mice successive administration 5 days, after the administration 1 hour the last time, drip in mouse right ear with 100% dimethylbenzene 0.2ml, left ear is done contrast.Behind the 30min dislocation of mice cervical vertebra is caused death, cut two ears, lay the garden auricle at the same position of left and right sides ear respectively, divide torsion balance to weigh, ask left and right sides auricle weight difference with the card punch of diameter 9mm along the auricle baseline, as the swelling degree, comparable group differences significance.
4, experimental result:
| Group | Dosage (mg/kg) | The Mus number | The ear degree (mg) that swells |
| Solvent control | 15 | 1.85±0.24 | |
| Aspirin | 100 | 15 | 0.68±0.31 ** |
| The twinge gram | 800 | 15 | 1.08±0.25 ** |
| 400 | 15 | 1.14±0.32 * | |
| 200 | 15 | 1.16±0.43 |
*P＜0.05,
*Compare with the solvent control group p＜0.01
Two, analgesic activity:
(1) mice hot plate method:
1, the female kunming mice of method: 26～30g is divided into 5 groups at random, 15 every group.Experiment divides dosage group (400mg/kg), twinge gram low dose group (200mg/kg) in solvent control group (0.1%CMC), morphine (5mg/kg), twinge gram high dose group (800mg/kg), the twinge gram.
2, route of administration: (1) twinge gram: irritate stomach (ig).Administration volume: 20ml/kg.
(2) morphine: lumbar injection (ip).Administration volume: 10ml/kg.
3, experimental implementation:
Mice is placed on 55 ℃ of metallic plates, and with the index of kicking, licking metapedes, jumping and reacting as pain, the threshold of pain stays for testing with interior mice at 30s and uses.
Mice successive administration 5 days, beginning in 1 hour after the administration is the last time measured every Mus threshold of pain every 15min, continuous 2 hours.The significance of comparable group differences.Surpass 60s and represent that analgesic activity is arranged, take out mice immediately.
4, experimental result:
| Group | Dosage mg/kg | Pain threshold (s) | |||
| Value before the medicine | 30min behind the medicine | 60min behind the medicine | 90min behind the medicine | ||
| Solvent control | 18.8±2.8 | 19.3±3.6 | 20.2±2.6 | 21.3±4.2 | |
| Morphine | 5 | 18.5±3.1 | 34.5±3.7 ** | 38.1±3.2 ** | 40.2±3.9 ** |
| The twinge gram | 800 | 19.2±1.3 | 31.2±3.1 ** | 28.7±2.1 * | 32.7±2.3 ** |
| 400 | 18.9±2.2 | 27.6±2.3 ** | 26.5±1.8 * | 30.5±1.9 ** | |
| 200 | 19.7±2.0 | 20.3±2.1 * | 26.1±2.1 * | 26.4±2.88 | |
*P＜0.05,
*Compare with the solvent control group p＜0.01
(2) writhing method
1, method: 26～30g male mouse of kunming is divided into 5 groups, 15 every group at random.Experiment divides dosage group (400mg/kg), twinge gram low dose group (200mg/kg) in solvent control group (0.1%CMC), aspirin 100mg/kg, twinge gram high dose group (800mg/kg), the twinge gram.
2, route of administration: irritate stomach (ig); Administration volume: 20ml/kg.
3, experimental implementation: mice successive administration 5 days, beginning in 1 hour after the administration the last time.Mouse peritoneal is injected acetic acid 0.2ml/ of 0.6% fresh configuration, writes down in every Mus 15min and turns round the body number.
4, experimental result:
| Group | Dosage (mg/kg) | The Mus number | Turn round the body number of times | Turn round body suppression ratio (%) |
| Solvent control | 15 | 70.7±16.5 | ||
| Aspirin | 100 | 15 | 17.2±2.2 ** | 76 |
| The twinge gram | 800 | 15 | 21.4±10.3 ** | 69.7 |
| 400 | 15 | 36.8±13.6 ** | 48 | |
| 200 | 15 | 47.2±11.2 | 33.3 |
*P＜0.05,
*Compare with the solvent control group p＜0.01
Three, conclusion (of pressure testing): this test shows that the twinge gram has antiinflammatory and analgesic activity, and dosage and time-dependent relation are arranged.
Claims (5)
1, a kind of compound Chinese patent medicine that is used for the treatment of bone stitch is characterized in that the compound Chinese patent medicine agent that it is made by following Chinese crude drug raw material by weight ratio:
Fructus Rubi 200～220, Rhizoma Drynariae 88～94, Semen Cuscutae 57～63, Fructus Schisandrae Chinensis 47～52, Fructus Rosae Laevigatae 38～43, Herba Epimedii 28～32, Poria 29～33, Radix Morindae Officinalis 27～31, Herba Cynomorii 18～22, Fructus Cnidii 28～33, Herba Cistanches 27～33.
2, a kind of compound Chinese patent medicine that is used for the treatment of bone stitch according to claim 1 is characterized in that pharmaceutical preparation is tablet, capsule, granule.
3, the described a kind of preparation method that is used for the treatment of the compound Chinese patent medicine of bone stitch of claim 1 is characterized in that: press following weight proportion weighing Chinese crude drug raw material:
Fructus Rubi 200～220, Rhizoma Drynariae 88～94, Semen Cuscutae 57～63, Fructus Schisandrae Chinensis 47～52, Fructus Rosae Laevigatae 38～43, Herba Epimedii 28～32, Poria 29～33, Radix Morindae Officinalis 27～31, Herba Cynomorii 18～22, Fructus Cnidii 28～33, Herba Cistanches 27～33;
After above-mentioned load weighted Chinese crude drug raw material selected, cleans, twice of 70～90% alcohol heating reflux of 7～12 times of amounts of adding, each 0.5～2.5 hour, filter, the filtrate concentrate drying, pulverize Chinese medicine extract, granulate after crossing 80～120 mesh sieves, divide the capsule of packing into, or the adding pharmaceutic adjuvant is pressed into tablet or is distributed into granule.
4, a kind of preparation method that is used for the treatment of the compound Chinese patent medicine of bone stitch according to claim 3 is characterized in that Chinese medicine extract and pharmaceutic adjuvant weight proportion are 1: 0.5～4.
5, a kind of preparation method that is used for the treatment of the compound Chinese patent medicine of bone stitch according to claim 3 is characterized in that pharmaceutic adjuvant selects a kind of or mixture in Pulvis Talci, microcrystalline Cellulose, starch, magnesium stearate, cane sugar powder, the dextrin for use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610085406XA CN100459993C (en) | 2006-06-14 | 2006-06-14 | Compound Chinese medicine for treating bone stitch and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610085406XA CN100459993C (en) | 2006-06-14 | 2006-06-14 | Compound Chinese medicine for treating bone stitch and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1895403A true CN1895403A (en) | 2007-01-17 |
| CN100459993C CN100459993C (en) | 2009-02-11 |
Family
ID=37608141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200610085406XA Active CN100459993C (en) | 2006-06-14 | 2006-06-14 | Compound Chinese medicine for treating bone stitch and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100459993C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103585319A (en) * | 2013-11-26 | 2014-02-19 | 刘耿熙 | Traditional Chinese medicine composition for curing flaccid paralysis caused by liver-kidney deficiency and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100444882C (en) * | 2004-12-30 | 2008-12-24 | 贵州恒霸药业有限责任公司 | Capsules for zhongtongling for bone fracture and soft tissue injury and their making method |
-
2006
- 2006-06-14 CN CNB200610085406XA patent/CN100459993C/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103585319A (en) * | 2013-11-26 | 2014-02-19 | 刘耿熙 | Traditional Chinese medicine composition for curing flaccid paralysis caused by liver-kidney deficiency and preparation method thereof |
| CN103585319B (en) * | 2013-11-26 | 2015-10-28 | 李秀华 | A kind ofly treat Chinese medicine composition of flaccidity caused by deficiency of both the liver and kidney and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100459993C (en) | 2009-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007234B (en) | Traditional Chinese medicine preparation for treating dysmenorrheal caused by endometriosis and preparation method of preparation | |
| CN104666698A (en) | External-use traditional Chinese medicine ointment for treating gonarthromeningitis and preparation method of traditional Chinese medicine ointment | |
| CN104666579A (en) | Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method of traditional Chinese medicine composition | |
| CN104435169A (en) | Traditional Chinese medicine combination for treating bone injury and fracture and preparation method of traditional Chinese medicine combination | |
| CN109432269A (en) | A kind of Chinese medicine composition and preparation method, purposes | |
| CN102772712A (en) | Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot | |
| CN102178781B (en) | Chinese medicine composition for treating scrotum eczema and preparation method thereof | |
| CN105435197A (en) | Pharmaceutical composition for treating chronic lymphocytic thyroiditis and preparation method thereof | |
| CN100459993C (en) | Compound Chinese medicine for treating bone stitch and its preparation | |
| CN104398962A (en) | Chinese medicinal composition for treating spleen and kidney deficiency type lumbar muscle degeneration and preparation method thereof | |
| CN104042774A (en) | Medicine composition for treatment of osteoporosis | |
| CN102552743A (en) | Medicinal composition for treating diabetes and preparation method thereof | |
| CN102091254B (en) | Traditional Chinese medicine composition for relieving swelling after cosmetic surgery and preparation method thereof | |
| CN101057954B (en) | Traditional Chinese medicine compound for treating transient ischemic attack and its preparation method | |
| CN104758701A (en) | Medicament for nursing treatment of stomach stones after lithotripsy and preparation method of medicament | |
| CN1742775A (en) | Medicine composition for preventing and treating orthopedic diseases | |
| CN105343808A (en) | Traditional Chinese medicine composition with weight reducing effect and preparation method of traditional Chinese medicine composition | |
| CN103417836B (en) | Chinese medicine composition for the treatment of tumor and preparation method thereof | |
| CN106177469A (en) | A kind of Chinese medicine composition treating cyclomastopathy and preparation method thereof | |
| CN105031335A (en) | Medicament for nursing and treatment after microwave pulverization of gastric bezoars and its preparation method | |
| CN105920189A (en) | Traditional Chinese medicine composition for treating talalgia due to liver-kidney deficiency and preparation method thereof | |
| CN106074813A (en) | A kind of Chinese medicine fumigation and washing soaking agent treating talalgia and preparation method thereof | |
| CN103933359A (en) | Pharmaceutical composition for dispelling keloid and preparation method of pharmaceutical composition | |
| CN104857371A (en) | Medicine for treating colon cancer and preparation method thereof | |
| CN104398888A (en) | Chinese medicinal composition for treating kidney yin deficiency type lumbar muscle degeneration and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: JIANGSU PENGYAO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHANG GUOQING Effective date: 20100407 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 214205 JIANGSU PENGYAO PHARMACEUTICAL CO., LTD., NO.69, LONGCHI ROAD, YICHENG TOWN, YIXING CITY, JIANGSU PROVINCE TO: 214205 NO.69, LONGCHI ROAD, YICHENG TOWN, YIXING CITY, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20100407 Address after: 214205 Jiangsu province Yixing Yicheng town dragon Chi Lu No. 69 Patentee after: Jiangsu Pengyao Pharmaceutical Inc. Address before: 214205 Jiangsu province Yixing Yicheng town dragon Chi Lu No. 69 Jiangsu Pengyao Pharmaceutical Co., Ltd. Patentee before: Zhang Guoqing |